MultiPlan Past Earnings Performance
Past criteria checks 0/6
MultiPlan's earnings have been declining at an average annual rate of -29%, while the Healthcare Services industry saw earnings growing at 2.8% annually. Revenues have been growing at an average rate of 1.1% per year.
Key information
-29.0%
Earnings growth rate
-25.3%
EPS growth rate
| Healthcare Services Industry Growth | 1.7% |
| Revenue growth rate | 1.1% |
| Return on equity | -5.4% |
| Net Margin | -9.5% |
| Next Earnings Update | 08 May 2024 |
Recent past performance updates
Recent updates
Estimating The Intrinsic Value Of MultiPlan Corporation (NYSE:MPLN)
Apr 23
Why Investors Shouldn't Be Surprised By MultiPlan Corporation's (NYSE:MPLN) 26% Share Price Plunge
Mar 13MultiPlan (NYSE:MPLN) Has A Somewhat Strained Balance Sheet
Mar 05Insufficient Growth At MultiPlan Corporation (NYSE:MPLN) Hampers Share Price
Jan 08MultiPlan Sees Uptick In Utilization But Revenue Growth Is A Challenge
Oct 27Revenues Working Against MultiPlan Corporation's (NYSE:MPLN) Share Price
Oct 02MultiPlan Sees Stabilizing Markets But Contracting Revenue In 2023
Jul 13MultiPlan Corporation: Stay Away From The Stock In The Near Term
Jan 07MultiPlan Corporation (NYSE:MPLN) Analysts Just Trimmed Their Revenue Forecasts By 15%
Nov 18Multiplan Corporation GAAP EPS of $0.03 in-line, revenue of $250.5M misses by $34.7M
Nov 08MultiPlan Corporation: Adding This Growing Healthcare Tech Play To The 'Bio Boom' Portfolio
May 23MultiPlan Corporation (NYSE:MPLN) Just Released Its Annual Earnings: Here's What Analysts Think
Feb 20MultiPlan Corporation's (NYSE:MPLN) Intrinsic Value Is Potentially 67% Above Its Share Price
Jul 04Could The MultiPlan Corporation (NYSE:MPLN) Ownership Structure Tell Us Something Useful?
Feb 15Revenue & Expenses BreakdownBeta
How MultiPlan makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 962 | -92 | 136 | 0 |
| 30 Sep 23 | 958 | -710 | 98 | 0 |
| 30 Jun 23 | 966 | -667 | 121 | 0 |
| 31 Mar 23 | 1,018 | -617 | 129 | 0 |
| 31 Dec 22 | 1,080 | -573 | 132 | 0 |
| 30 Sep 22 | 1,137 | 102 | 158 | 0 |
| 30 Jun 22 | 1,175 | 161 | 136 | 0 |
| 31 Mar 22 | 1,161 | 100 | 135 | 0 |
| 31 Dec 21 | 1,118 | 102 | 141 | 0 |
| 30 Sep 21 | 1,075 | -96 | 197 | 0 |
| 30 Jun 21 | 1,010 | -463 | 334 | 0 |
| 31 Mar 21 | 941 | -472 | 330 | 0 |
| 31 Dec 20 | 938 | -521 | 323 | 0 |
| 30 Sep 20 | 929 | -335 | 254 | 0 |
| 30 Jun 20 | 951 | -42 | 104 | 0 |
| 31 Mar 20 | 990 | 11 | 87 | 0 |
| 31 Dec 19 | 983 | 10 | 75 | 0 |
| 31 Dec 18 | 1,041 | 36 | 78 | 0 |
| 31 Dec 17 | 1,067 | 648 | 123 | 0 |
Quality Earnings: MPLN is currently unprofitable.
Growing Profit Margin: MPLN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MPLN is unprofitable, and losses have increased over the past 5 years at a rate of 29% per year.
Accelerating Growth: Unable to compare MPLN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MPLN is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (15.4%).
Return on Equity
High ROE: MPLN has a negative Return on Equity (-5.37%), as it is currently unprofitable.